Sarah Gheuens
Chief Medical Officer at Agios Pharmaceuticals, Inc. (AGIO)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Aug 6SEC | AGIOAgios Pharmaceuticals, Inc. | Sell Plan | 30,00054,645 held (−35%) | $30.48 | $914K | +4.4% |
| Jul 2SEC | AGIOAgios Pharmaceuticals, Inc. | Sell Plan | 4,00784,645 held (−5%) | $37.56 | $151K | -15.3% |
| Apr 6SEC | AGIOAgios Pharmaceuticals, Inc. | Sell Plan | 2,94080,277 held (−4%) | $34.71 | $102K | -8.4% |
| Mar 3SEC | AGIOAgios Pharmaceuticals, Inc. | Sell Plan | 1,18767,608 held (−2%) | $28.96 | $34K | +9.8% |
| Mar 3SEC | AGIOAgios Pharmaceuticals, Inc. | Sell Plan | 1,68171,593 held (−2%) | $28.96 | $49K | +9.8% |
| Mar 3SEC | AGIOAgios Pharmaceuticals, Inc. | Sell Plan | 1,18774,406 held (−2%) | $28.96 | $34K | +9.8% |
| Jan 2SEC | AGIOAgios Pharmaceuticals, Inc. | Sell Plan | 2,93264,795 held (−4%) | $27.09 | $79K | +17.4% |
| Nov 13SEC | AGIOAgios Pharmaceuticals, Inc. | Sell Plan | 2,45461,727 held (−4%) | $43.78 | $107K | -27.3% |
| Nov 3SEC | AGIOAgios Pharmaceuticals, Inc. | Sell Plan | 20061,727 held (−0%) | $43.81 | $9K | -27.4% |
| Oct 29SEC | AGIOAgios Pharmaceuticals, Inc. | Sell Plan | 3,30261,727 held (−5%) | $43.92 | $145K | -27.6% |
- Sell
Chief Medical Officer Sarah Gheuens sold $914K of AGIO at $30.48 — cuts the stake by 35%; pre-scheduled 10b5-1 plan sale.
- Sell
Chief Medical Officer Sarah Gheuens sold $151K of AGIO at $37.56 — pre-scheduled 10b5-1 plan sale.
- Sell
Chief Medical Officer Sarah Gheuens sold $102K of AGIO at $34.71 — pre-scheduled 10b5-1 plan sale.
- Sell
Chief Medical Officer Sarah Gheuens sold $34K of AGIO at $28.96 — pre-scheduled 10b5-1 plan sale.
- Sell
Chief Medical Officer Sarah Gheuens sold $49K of AGIO at $28.96 — pre-scheduled 10b5-1 plan sale.
- Sell
Chief Medical Officer Sarah Gheuens sold $34K of AGIO at $28.96 — pre-scheduled 10b5-1 plan sale.